ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #616Top JournalReview JournalHybrid

Cytokine & Growth Factor Reviews

Acronym:cgfr
•
Abbreviation (ISO):CYTOKINE GROWTH FACTOR REV
•
Identifier (ISSN):1359-6101(Print)/1879-0305(Online)
•
Publisher:Elsevier BV
Clarivate IF (2026)
13.4↑ +1.6
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Cytokine & Growth Factor Reviews

WoS Q1
31016236.3920185.4620195.9820207.64202117.7202213.020239.3202411.8202513.42026
Annual Impact Factor Metric
Current (2026):13.4
Scopus SJR & RankScopus Q1
3.297
#616

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
193

193 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate1.1%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
60articles/year
28.42% Gold OA•0% Original Research

Aims & Scope

Cytokine & Growth Factor Reviews publishes thought-provoking articles (critical reviews, state-of-the-art reviews, letters to the editor, meeting reviews) devoted to important advances in the rapidly changing fields of growth factor and cytokine research. Major emphasis is placed on the multidisciplinary significance of cytokines and growth factors in areas as diverse as signal transduction, cell growth and differentiation, embryonic development, immunology, tumorigenesis and clinical medicine.

Topics Covered (Recognized by AI)
Medicine88.9%Biology88.8%Genetics83.9%Internal medicine81.1%Chemistry73.5%Biochemistry73%Immunology66.2%Cell biology53.2%Receptor48.6%Immune system44.2%Gene40.2%Pathology32%Cancer research29.5%Signal transduction28.6%Endocrinology26.4%Cytokine26.3%Inflammation25.2%Cancer22.4%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q1
Rank21/328
IndexSCIE
JCRSCIE2026

CELL BIOLOGY

Q1
Rank24/207
IndexSCIE
JCISCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q1
Rank67/328
IndexSCIE
JCISCIE2026

CELL BIOLOGY

Q2
Rank57/207
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF13.4
Articles / Year47
Total Citations53
2025
IF11.8
Articles / Year77
Total Citations978
2024
IF9.3
Articles / Year61
Total Citations1,403
2023
IF13
Articles / Year61
Total Citations2,081
2022
IF17.66
Articles / Year54
Total Citations2,351

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #616Scopus Q1SCImago Profile
Scopus Coverage:1996-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q1
3.297

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
13.06

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,026 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,098
3-Year Documents158
Citable Documents156

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate40.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Biochemistry, Genetics and Molecular Biology (miscellaneous)Q1
Endocrinology, Diabetes and MetabolismQ1
ImmunologyQ1
Immunology and AllergyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 1.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区BIOCHEMISTRY & MOLECULAR BIOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cytokine & Growth Factor Reviews (acronym: cgfr, abbr: CYTOKINE GROWTH FACTOR REV, ISSN: 1359-6101) is a peer-reviewed international scholarly journal in the field of Biology, published by Elsevier BV in England since 1996. The periodical holds a Journal Impact Factor (JIF) of 13.4, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 3.297 (Q1), an H-index of 193.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 60 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,026 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier BV
Publication Language
English
Frequency
Bimonthly
Founding Year
1996
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: f45bce4e-598c-4d74-a422-af21db2a5fad
Database Updated: 2026-10-16